Error: Could not add to watchlist. X

AbbVie Biotherapeutics Inc

+ Watchlist
FACT:US
Acquired
FACT:US was acquired by ABBV:US
USD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-5.11
Market Cap (USD)
-
Shares Outstanding (m)
25.093
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
AbbVie Biotherapeutics Inc. operates as a biopharmaceutical company. The Company develops drugs for the treatment of multiple sclerosis, ovarian and lung cancers, multiple myeloma, tumors, and immune system diseases. AbbVie Biotherapeutics serves clients worldwide.
ADDRESS
1 North Waukegan Road
North Chicago, IL 60064-6163
United States
PHONE
1-800-255-5162
  • Ted Llana
    Senior VP:Commercial & Devp
Show More